Allarity Therapeutics Inc. - Bathi resik saben siji saham sajrone rolas wulan pungkasan ALLR

Allarity Therapeutics (ALLR) - logo korporat

Allarity Therapeutics protects its business through proprietary biomarker analysis algorithms. The historical EPS YoY TTM trend on the GURU.Markets chart shows that the figure stands at 38.70. Allarity Therapeutics attracts bioinformatics experts via a DNA-based therapy selection IT platform. However, the lack of stable profit sources makes the company's financial condition entirely dependent on the inflow of external investments.

Allarity Therapeutics (ALLR): Bathi resik saben saham sajrone 12 wulan pungkasan saka 11.02.2024 nganti 18.11.2026

Rincian metrik keuangan lan pasar Allarity Therapeutics, Inc. (ALLR)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:ALLR, Allarity
Produk asli allarity.com

Allarity Therapeutics' struggle for survival in the personalized oncology segment amid a capital shortage makes the analysis of business efficiency critical. The 12-month earnings per share trend, which reached 38.70, allows investors to filter out market noise and assess the actual expansion of operational scale, making the relative YoY (ttm) EPS change a key filter against overpaying for the asset.